NASDAQ: NVNO - enVVeno Medical Corporation

Yield per half year: -46.51%
Dividend yield: 0.00%
Sector: Healthcare

Share chart enVVeno Medical Corporation

Extended chart Simple chart
Financial Markets by TradingView

About enVVeno Medical Corporation

enVVeno Medical Corporation, a clinical med-tech company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of chronic venous disease. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021.

more details
enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2018-05-31
ISIN US29415J1060
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.envveno.com
Цена ао 2.79
Change price per day: +4.3% (2.79)
Change price per week: -5.21% (3.07)
Change price per month: -12.35% (3.32)
Change price per 3 month: +2.11% (2.85)
Change price per half year: -46.51% (5.44)
Change price per year: -51.09% (5.95)
Change price per 3 year: -43.39% (5.14)
Change price per 5 year: +309.28% (0.711)
Change price per year to date: +13.23% (2.57)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 1.32 9
P/E 0 0
EV/EBITDA -2.39 0
Total: 3.63

Efficiency

Title Value Grade
ROA, % -48.35 0
ROE, % -50.9 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0568 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % -96.06 0
Yield Ebitda, % 279.06 10
Yield EPS, % -84.2 0
Total: 6
More

Institutions Volume Share, %
Nantahala Capital Management, LLC 1412638 10.61
Perceptive Advisors LLC 623315 4.68
Kingdon Capital Management LLC 619180 4.65
Armistice Capital, LLC 436000 3.27
Altium Capital Management, LP 344471 2.59
Vanguard Group Inc 336405 2.53
Rosalind Advisors, Inc. 312091 2.34
UBS OConnor LLC 236308 1.77
Velan Capital Investment Management LP 172235 1.29
Geode Capital Management, LLC 122116 0.92

ETFShare, %Profitability for 1 year, %Dividends, %
iShares Micro-Cap ETF 0.01259 17.09 1.54048
0.0117.091.54



Head Job title Payment Year of birth
Mr. Robert A. Berman CEO & Director 1.02M 1963 (62 years)
Mr. Craig Thomas Glynn CFO, Treasurer & Secretary 313.69k 1961 (64 years)
Dr. Hamed Alavi Ph.D. Senior VP & Chief Technology Officer 384.39k
Dr. Marc H. Glickman M.D. Senior VP & Chief Medical Officer 491.59k 1949 (76 years)
Mr. Warren Hancock Co-founder N/A
Dr. Benedict Broennimann M.D. Chief Medical Officer of Outside of United States 240k 1957 (68 years)
Mr. Andrew Cormack Chief Commercial Officer N/A
Ms. Sandy Prietto Vice President of Marketing

Address: United States, Irvine. CA, 70 Doppler - open in Google maps, open in Yandex maps
Website: https://www.envveno.com